Invitrogen™ Human EVER2 Synthetic Peptide

Catalog No.	Quantity
PEP0647	50 μg

Catalog No. PEP0647 Supplier Invitrogen™ Supplier No. PEP0647

Description

Synthetic Peptide

EVER2 Synthetic Peptide, PEP-0647, from Invitrogen.

Epidermodysplasia verruciformis (EV) is an autosomal recessive genodermatosis associated with a high risk of skin cancers resulting from a high susceptibility to infection by specific human papillomaviruses. Mutations in two homologous genes EVER1 and EVER2 cause the majority of EV cases. These two proteins form a complex and interact with the zinc transporter ZnT-1 in the endoplasmic reticulum. Cells lacking EVER2 accumulated higher levels of zinc in the nucleolus and nucleus compare to those cells with and intact EVER2 gene, indicating that one role of EVER2 is to regulate the intracellular distribution of zinc.

Specifications

• Gene ID (Entrez): 147138
• Species: Human
• Purification Method: purified
• Accession Number: Q8IU68
• Common Name: Human EVER2
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: TMC8
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS